R
Richard E. Champlin
Researcher at University of Texas MD Anderson Cancer Center
Publications - 1500
Citations - 73470
Richard E. Champlin is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Transplantation & Hematopoietic stem cell transplantation. The author has an hindex of 138, co-authored 1402 publications receiving 66917 citations.
Papers
More filters
Journal ArticleDOI
Donor type, in addition to transplantation in chronic phase and myeloablative conditioning, influence transplant survival for patients with advanced chronic myeloid leukemia in the era of tyrosine kinase inhibitors.
Piyanuch Kongtim,Kehinde Adekola,Denái R. Milton,R. Ramlal,A. Jimenez,J. Chen,Gabriela Rondon,Sairah Ahmed,Partow Kebriaei,Oran Betul,Chitra Hosing,U. Popat,Issa F. Khouri,E. Jabbour,Jorge E. Cortes,Hagop M. Kantarjian,Richard E. Champlin,Stefan O. Ciurea +17 more
TL;DR: Donor type, in addition to transplantation in chronic phase and myeloablative conditioning, influence transplant survival for patients with advanced chronic myeloid leukemia in the era of tyrosine kinase inhibitors.
Book ChapterDOI
The Role of Allogeneic Stem Cell Transplantation in the Therapy of Adult Acute Lymphoblastic Leukemia (ALL)
TL;DR: This chapter defines the different disease risk groups, the clinical outcomes of major transplant trials for ALL, and the therapeutic factors that affect outcome after SCT.
Journal ArticleDOI
Improved outcomes of high-risk relapsed Hodgkin lymphoma patients after high-dose chemotherapy: a 15-year analysis.
Yago Nieto,Stephen K. Gruschkus,Benigno C. Valdez,Roy B. Jones,Paolo Anderlini,Chitra Hosing,Uday R. Popat,Muzaffar H. Qazilbash,Partow Kebriaei,Amin M. Alousi,Neeraj Saini,Samer A. Srour,Katayoun Rezvani,Jeremy Ramdial,Melissa Barnett,Alison M. Gulbis,Terri Lynn Shigle,Sairah Ahmed,Swaminathan Padmanabhan Iyer,Hun Lee,Ranjit Nair,Simrit Parmar,Raphael E Steiner,Bouthaina S. Dabaja,Chelsea C. Pinnix,Jillian R. Gunther,Branko Cuglievan,Kris Michael Mahadeo,Sajad Khazal,Hubert H. Chuang,Richard E. Champlin,Elizabeth J. Shpall,Borje S. Andersson +32 more
TL;DR: In this article, the authors retrospectively analyzed all HRR cHL patients treated with high-dose chemotherapy and autologous stem-cell transplant (HDC/ASCT) at their institution between 1/01/2005-12/31/2019.
Journal ArticleDOI
Optimizing the Composition of Bone Marrow for Allogeneic Transplantation
TL;DR: This review describes recent developments that employ ex vivo engineering of the graft to modify the cellular composition to overcome problems of graft versus host disease, graft failure, and disease relapse.